Glucotrack, Inc. Enters Material Definitive Agreement

Ticker: GCTK · Form: 8-K · Filed: Nov 18, 2024 · CIK: 1506983

Glucotrack, INC. 8-K Filing Summary
FieldDetail
CompanyGlucotrack, INC. (GCTK)
Form Type8-K
Filed DateNov 18, 2024
Risk Levelmedium
Pages4
Reading Time4 min
Key Dollar Amounts$0.001, $4,093,112
Sentimentneutral

Sentiment: neutral

Topics: material-agreement, filing-update

TL;DR

Glucotrack signs a big deal, filing shows new agreement and financials.

AI Summary

Glucotrack, Inc. filed an 8-K on November 18, 2024, reporting the entry into a material definitive agreement on November 12, 2024. The filing also includes financial statements and exhibits related to this agreement. The company, formerly known as Integrity Applications, Inc., is based in Rutherford, NJ.

Why It Matters

This filing indicates a significant new contract or partnership for Glucotrack, Inc., which could impact its future financial performance and strategic direction.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement, which could be positive or negative depending on the terms, introducing a medium level of risk.

Key Players & Entities

FAQ

What is the nature of the material definitive agreement entered into by Glucotrack, Inc.?

The filing does not specify the nature of the material definitive agreement, only that one was entered into on November 12, 2024.

When was the 8-K filing submitted to the SEC?

The 8-K filing was submitted on November 18, 2024.

What was Glucotrack, Inc. previously named?

Glucotrack, Inc. was formerly known as Integrity Applications, Inc.

Where are Glucotrack, Inc.'s principal executive offices located?

Glucotrack, Inc.'s principal executive offices are located at 301 Rte. 17 North, Ste. 800, Rutherford, NJ 07070.

What is the SIC code for Glucotrack, Inc.?

The Standard Industrial Classification (SIC) code for Glucotrack, Inc. is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

Filing Stats: 1,083 words · 4 min read · ~4 pages · Grade level 14.1 · Accepted 2024-11-18 17:05:08

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 18, 2024 GLUCOTRACK, INC. By: /s/ Paul Goode Name: Paul Goode Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing